amwell wegovy semaglutide partnership for the Treatment of Chronic Weight Management, US EMA CHMP recommends label update

But she ate just a quarter of it, put the rest away, and didn't photograph the dish for social media for the first time she could remember

doi: 10.1016/j.neubiorev.2016.02.002 183 SmithK

Safety, tolerability, pharmacokinetics and pharmacodynamics of albiglutide, a long-acting GLP-1-receptor agonist, in Japanese subjects with type 2 diabetes mellitus

The FDA label includes a boxed warning about thyroid C-cell tumors observed in rodent studies, though the relevance to humans remains uncertain

The eMC SmPC for orlistat (Xenical/Alli) advises that the two medicines should be separated by at least 4 hours, and that thyroid function should be monitored after orlistat is initiated typically at around 68 weeks with levothyroxine dose adjustment as required

As a skeptic, I am allergic to the word miracle, but when we look at the data for GLP receptor agonists, along with the innumerable before and after photos of successful weight loss transformations, we are forced to admit that we have moved from a realm of wishful thinking into one of potent pharmacology